Hussman Strategic Advisors, Inc. Vanda Pharmaceuticals Inc. Transaction History

Hussman Strategic Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	BUY	$15.69 - $21.14 $502,080 - $676,480	32,000 Added 25.81%	156,000 $2.45 Million
Q3 2021 Nov 01, 2021	BUY	$15.35 - $21.27 $475,850 - $659,370	31,000 Added 33.33%	124,000 $2.13 Million
Q2 2021 Aug 03, 2021	BUY	$15.71 - $21.51 $329,910 - $451,710	21,000 Added 29.17%	93,000 $2 Million
Q1 2021 May 03, 2021	BUY	$13.42 - $20.28 $281,820 - $425,880	21,000 Added 41.18%	72,000 $1.08 Million
Q4 2020 Feb 01, 2021	BUY	$9.77 - $13.81 $156,320 - $220,960	16,000 Added 45.71%	51,000 $670,000
Q3 2020 Nov 02, 2020	BUY	$9.32 - $12.02 $326,200 - $420,700	35,000 New	35,000 $338,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.